Oncoinvent AS: Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes

Publications highlight the safety and tolerability of Radspherin for patients and those externally exposed to radiation, all dose levels were well tolerated with dose level toxicity (DLT) not reached.

Related Keywords

Bruxelles ,Bruxelles Capitale ,Belgium ,Michel Goldman Universit ,Courtney Turiano ,Jana Alfheim ,Linear Energy Transfer ,Chief Executive Officer ,Field Chief Editor Prof Michel Goldman ,Stern Investor Relations ,Oncoinvent ,Nnounces ,Publications ,Special ,Eedition ,Frontiers ,Medicine ,Ocused ,Lpha ,Radioisotopes ,